Distinguished Scientist Golden Lionel Award

Distinguished Scientist Golden Lionel Award

A. Raviele – Congress President

awards S. Viskin

History never looks like history when you are living through it
Sami-Viskin

Sami Viskin

Sami Viskin is the Director of the Cardiac Hospitalization Department at the Tel-Aviv Medical Center and Associate Professor of Cardiology at the Tel Aviv University in Israel. He serves as Section Editor in Heart Rhythm and served as Associate Editor in both Heart Rhythm and Europace.

Sami has received the following awards: The Michel Mirowsky Award in Cardiology in Israel, the Distinguished Teacher award from Tel Aviv University, the Distinguished Physician award from Tel Aviv Medical Center, a Distinguished Reserve Officer award from the Israel Defence Forces, the “Elite Reviewer” Award from JACC, the Century Reviewer Award from Heart Rhythm the Simon Dack Award for Outstanding Scholarship from the Journal of the American College of Cardiology, the Best Publication on the Clinical Studies Category in HeartRhythm, 2014, the Distinguished Cardiologist of the Asociación Nacional de Cardiólogos de México, 2014 and the Best Abstract in the Clinical Catergory. Cardiac Electrophysiology Society, 2014.

Sami is a Task Force Member in 1) the AHA, Position Paper on Analysis of the 12-lead ECG as a Screening Test for Detection of Cardiovascular Disease in General Populations of Young Healthy People (ages 12-22 years) 2014. 2) EHRA Position Paper on Management of patients with palpitations. 2014. 3) EHRA Position Paper on Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death, 2015. 3) AHA Scientific Advisory on Electrocardiographic Early Repolarization, 2015.
Sami has 180 publications in peer reviewed journals, mainly dealing with the long QT syndrome, Brugada syndrome and idiopathic ventricular fibrillation. He described the ‘quick standing test” often referred to as “the Viskin test” for diagnosing long QT syndrome. He has struggle to solve the problem of unavailability of quinidine in numerous countries.